The aim of this study was to elucidate differences in the histological features of rectal cancer between patients treated with preoperative chemoradiotherapy and those treated with preoperative chemotherapy. Area of residual tumor (ART) was also evaluated for its utility as a potential prognostic marker between them. Sixty-eight patients with rectal cancer who underwent sphincter-saving surgery were enrolled in this study. Of these, 39 patients received preoperative chemoradiotherapy (CRT group) and 29 patients received preoperative (neoadjuvant) chemotherapy (NAC group). Area of residual tumor was determined by using morphometric software. 
Given that preoperative NAC could represent a potential alternative to CRT and provide better local control without anal dysfunction, 7, 8 NAC with FOLFOX was attempted and a detailed pathological assessment was compared patients undergoing NAC with those undergoing other preoperative therapy, to provide information on how preoperative therapies differ in their histological effects. Next, the effect of preoperative therapy was pathologically evaluated in terms of TRG according to the Dworak or CAP criteria, although TRG remains yet to be standardized. 9, 10 We have reported the utility of measuring ART in gastric, lung, and rectal cancer. [11] [12] [13] However, no study has evaluated the availability of these assessment methods for various therapeutic regimens.
In this study, therefore, tumors from patients undergoing preoperative CRT vs those undergoing NAC 14 were compared for their histologic and clinicopathologic features. Histologic assessments reported after preoperative CRT and NAC were evaluated to investigate whether or not one single assessment may be applicable across a variety of preoperative therapies. and from 2010 to 2014, respectively. Preoperative clinical staging was carried out before and after preoperative therapy using the 7th UICC classification and staging system.
| MATERIALS AND METHODS

| Patients and clinical data collection
| Histologic assessment
All resected surgical specimens were fixed in 10% formalin. Tumor tissue was serially sliced in 5-mm longitudinal sections. Hematoxylineosin-stained sections were evaluated by two independent reviewers (M.K. and N.S.) who were blinded to their associated clinical findings.
Discrepancies between their findings were resolved by discussion. All tumors were examined for vascular, lymphovascular, and perineural invasion. To assess any histological alteration after therapy, all tumors were evaluated for the presence or absence of mucus lakes.
Tumors in which the mucus lakes constituted <10% of the entire tumor area were classified as grade A. Grades B and C reflected mucus lakes of 10%-30% and >30% of the tumor area, respectively. 15, 16 Tumor budding was defined as an isolated single cancer cell or a clus- All primary tumors were evaluated for degree of fibrosis on a 4-point scale. Grades 0, 1, 2, and 3 reflected <10%, 10%-24%, 25%-50% and >50% replacement of tumor tissue by fibrosis, respectively.
They were also evaluated for other histologic features of acidophilic degeneration of cytoplasm and calcification. 15, 16, 18 Pathologic finding of CRM positivity was defined as the distance between the tumor and the CRM of <1 mm in H&E staining. The WM-ART and BM-ART were morphometrically measured, and T-ART was calculated using tumor slices of the largest residual tumor. The ART was measured using viewer software, and mucus lakes were excluded. All tumor nests >0.1 mm 2 were measured for ART. The ART inside the inferior margin of the muscular layer was defined as WM-ART, and ART outside the inferior margin was defined as BM-ART. If the muscular layer was disrupted by inflammation, necrotic tissue, or fibrosis, a connecting line between the residual tumor muscular layers was drawn on the picture to discriminate between WM-ART and BM-ART ( Figure 1 ). 13 Excluded from ART analysis was mucosa showing ulceration, inflammation, necrosis, or adenoma components.
| Statistical analysis
The associations between ART and histopathologic tumor features were evaluated using the t-test. All calculated P-values were twosided, and P < .05 was considered statistically significant.
The overall accuracy of the potential variables in predicting the prognosis was summarized using the area under the ROC curves and compared by a non-parametric test for comparing areas under correlated ROC curves. 21, 22 Receiver operating characteristic curves to predict patient recurrence were drawn in the NAC and CRT groups. Cut-off values were obtained and used for the association between ART and clinicopathological features. All statistical analyses were carried out using JMP 13 software (SAS Institute, Cary, NC, USA).
3 | RESULTS Complete response rate was not significantly different between the NAC and CRT groups. (P = .33). Again, although ypT downstaging was not different between the groups, ypN downstaging was more frequently seen in the NAC group than in the CRT group (P = .001).
| Clinicopathologic characteristics
| Histopathologic features
The histopathologic features of tumors in the preoperative CRT and NAC groups are shown in Table 2 . Positive lymphatic vessel invasion was higher, and fibrosis grade was less in the NAC group than in the CRT group (P < .05). Grade 3 fibrosis was seen in >50% of patients who had undergone preoperative CRT. Histologic features reported post-therapy did not differ between the NAC and CRT groups, including acidophilic degeneration of cytoplasm, calcification, mucus lake, and budding grade.
| Area of residual tumor
Areas of residual tumors in the NAC and CRT groups are shown in Table 3 . Although there was no statistical difference in WM-ART and BM-ART between the groups, the CRT group was associated (A) (B)
F I G U R E 1 A, Low magnification view of H&E-stained section of rectal tumor tissue. B, Morphometric analysis used NanoZoomer Digital Pathology. Area of residual tumor (ART) was measured by tracing the outline of the tumor nests (black line). When the tumor was larger than 32 mm in size, we separated the slide and measured size. The border between the ART within the muscular layer (WM-ART) and the ART beyond the muscular layer (BM-ART) was measured by machine. The WM-ART was determined as the ART inside the inferior margin of the muscular layer, and BM-ART was measured as the ART outside the inferior margin of the muscular layer. If the muscular layer was not identified or had been displaced by inflammation, necrosis, and fibrosis, a connecting line between the muscular layers was drawn on the picture. In such cases, the area inside the line was measured as WM-ART and the area outside the line was measured as BM-ART. The total ART consisted of both areas CRT, respectively. The NAC and CRT groups were assessed for clinicopathologic features associated with ART. Table 4 shows the association between the clinicopathologic features and T-ART in NAC and CRT. Dworak and fibrosis grade were not associated with T-ART in either the NAC or CRT groups. There was a significant association between downstaging and T-ART in the NAC group. There was also a significant association between tumor budding/vascular invasion and T-ART in both the NAC and CRT groups. However, significant association between lymphatic/neural invasion and T-ART was shown to be associated only in the NAC group. , as well as negativity for lymphovascular invasion, were significantly associated with better DFS (P = .016, P = .04, P = .02, and P = .03, respectively). However, fibrosis and Dworak grades (0-3/4) were not associated with DFS. In NAC, downstaging, lower T and N grades, BM-ART (≤92.8 mm 2 ), T-ART (≤140.2 mm 2 ), and negativity for vascular and neural invasion were significant prognostic factors for better DFS (P = .0001, P = .016, P = .008, P = .0001, P = .015, P = .0012, and P = .0008, respectively). Fibrosis and Dworak grades (0-3/4) were not associated with DFS.
Multivariate analysis identified downstaging as an independent prognostic factor for NAC (Table 5 ), but no independent prognostic factor for CRT. Calcification n (%) 0 (0) 1 (2.6) .4700
Mucus lake, n (%) F I G U R E 2 Kaplan-Meier curves for disease-free survival curves for the impact of area of residual tumor (ART) on outcomes in circumferential resection margin-negative and pStage I-III patients with rectal cancer treated with neoadjuvant chemotherapy (NAC; n = 29) (A) and chemoradiotherapy (CRT; n = 39) (B). *P < .05. T-ART, total ART F I G U R E 3 A, Based on our area of residual tumor (ART) results, we propose an ART-based assessment method for patients with rectal cancer undergoing preoperative therapy. CR, complete response; CRT, chemoradiotherapy; NAC, neoadjuvant chemotherapy. B, The proposed new grading after preoperative therapy consists of four grades based on the microscopic magnifications and number of fields involved CRT vs NAC, where immune cells have been reported to be associated with postoperative convalescence and clinical outcome. [24] [25] [26] [27] [28] [29] [30] Therefore, other physiological features reflecting the state of the tumor microenvironment, such as hypoxia, might also be different between NAC and CRT. It has been thought that tumor hypoxia reduces sensitivity to chemotherapy and radiation, and tumor hypoxia also associated with prognosis factor to CRT. 31, 32 Further biological investigation is also required in the future.
The main limitation of this study is that the number of cases used to determine the cut-off level for ART with CRT vs NAC was small. Furthermore, a validation study is required to determine the utility of the proposed ART-based pathologic assessment.
In conclusion, histologic features of the preoperative CRT and NAC were elucidated. Pathological assessment based on ART could provide useful prognostic information for rectal cancer irrespective of therapeutic regimens. Further study is required to validate the proposed assessment method in the future.
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